Differential diagnosis of human hepatitis

  • Martin F. Sprinzl
  • Peter R. Galle
Part of the Birkhäuser Advances in Infectious Diseases book series (BAID)


There is a variety of differential diagnoses of acute and chronic human hepatitis regularly seen in clinical praxis. Risk factor assessment for specific entities provides important information and should guide individual diagnostic procedures. Liver screening tests often remain the first indicator for hepatic pathologies and should include quantification of liver enzymes, liver function parameters and cholestatic parameters. Nevertheless, virus serology should always be done during further laboratory evaluation. To estimate the parenchymal liver damage and to exclude biliary obstruction or hepatic lesions an abdominal ultrasound scan is essential. A liver biopsy may complete the diagnostic approach, if either the underlying hepatic pathology remains obscure or parenchymal liver damage needs to be defined.


Chronic Hepatitis Viral Hepatitis Hepatic STEATOSIS Acute Hepatitis Alcoholic Hepatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pendino GM, Mariano A, Surace P, Caserta CA, Fiorillo MT, Amante A, Bruno S, Mangano C, Polito I, Amato F et al (2005) Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town. Hepatology 41: 1151–1159PubMedCrossRefGoogle Scholar
  2. 2.
    Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98: 960–967PubMedCrossRefGoogle Scholar
  3. 3.
    Bellentani S, Tiribelli C (2001) The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol 35: 531–537PubMedCrossRefGoogle Scholar
  4. 4.
    Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS (1992) Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 10(Suppl 1): S59–62PubMedCrossRefGoogle Scholar
  5. 5.
    Emerson SU, Purcell RH (2004) Running like water-the omnipresence of hepatitis E. N Engl J Med 351: 2367–2368PubMedCrossRefGoogle Scholar
  6. 6.
    Alter MJ, Favero MS, Moyer LA, Miller JK, Bland LA (1990) National surveillance of dialysis-associated diseases in the United States, 1988. ASAIO Trans 36: 107–118PubMedCrossRefGoogle Scholar
  7. 7.
    Margolis HS, Alter MJ, Hadler SC (1991) Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 11: 84–92PubMedGoogle Scholar
  8. 8.
    Offergeld R, Faensen D, Ritter S, Hamouda O (2005) Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Euro Surveill 10: 8–11PubMedGoogle Scholar
  9. 9.
    Wasley A, Alter MJ (2000) Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20: 1–16PubMedCrossRefGoogle Scholar
  10. 10.
    Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Moyer LA, Fields HA, Bradley DW et al (1990) Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. Jama 264: 2231–2235PubMedCrossRefGoogle Scholar
  11. 11.
    Arevalo JA (1989) Hepatitis B in pregnancy. West J Med 150: 668–674PubMedGoogle Scholar
  12. 12.
    Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ (2006) Seroprevalence of cytomegalovirus infection in the United States, 1988–1994 Clin Infect Dis 43: 1143–1151PubMedCrossRefGoogle Scholar
  13. 13.
    Crawford DH, Macsween KF, Higgins CD, Thomas R, McAulay K, Williams H, Harrison N, Reid S, Conacher M, Douglas J et al (2006) A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin Infect Dis 43: 276–282PubMedCrossRefGoogle Scholar
  14. 14.
    Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE (2006) Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. Jama 296: 964–973PubMedCrossRefGoogle Scholar
  15. 15.
    Griffiths PD, Ellis DS, Zuckerman AJ (1990) Other common types of viral hepatitis and exotic infections. Br Med Bull 46: 512–532PubMedGoogle Scholar
  16. 16.
    Monath TP, Cetron MS (2002) Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 34: 1369–1378PubMedCrossRefGoogle Scholar
  17. 17.
    Deen JL, Harris E, Wills B, Balmaseda A, Hammond SN, Rocha C, Dung NM, Hung NT, Hien TT, Farrar JJ (2006) The WHO dengue classification and case definitions: time for a reassessment. Lancet 368: 170–173PubMedCrossRefGoogle Scholar
  18. 18.
    Geisbert TW, Jahrling PB (2004) Exotic emerging viral diseases: progress and challenges. Nat Med 10: S110–121PubMedCrossRefGoogle Scholar
  19. 19.
    Bianco E, Stroffolini T, Spada E, Szklo A, Marzolini F, Ragni P, Gallo G, Balocchini E, Parlato A, Sangalli M et al (2003) Case fatality rate of acute viral hepatitis in Italy: 1995-2000. An update. Dig Liver Dis 35: 404–408PubMedCrossRefGoogle Scholar
  20. 20.
    D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44: 217–231PubMedCrossRefGoogle Scholar
  21. 21.
    Yuen MF, Yuan HJ, Hui CK, Wong DK, Wong WM, Chan AO, Wong BC, Lai CL (2003) A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. Gut 52: 416–419PubMedCrossRefGoogle Scholar
  22. 22.
    Hausfater P, Cacoub P, Sterkers Y, Thibault V, Amoura Z, Nguyen L, Ghillani P, Leblond V, Piette JC (2001) Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France. Am J Hematol 67: 168–171PubMedCrossRefGoogle Scholar
  23. 23.
    Heckmann JG, Kayser C, Heuss D, Manger B, Blum HE, Neundorfer B (1999) Neurological manifestations of chronic hepatitis C. J Neurol 246: 486–491PubMedCrossRefGoogle Scholar
  24. 24.
    Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, Mal F, Callard P, Beaugrand M (1992) Lymphocytic sialadenitis of Sjogren’s syndrome associated with chronic hepatitis C virus liver disease. Lancet 339: 321–323PubMedCrossRefGoogle Scholar
  25. 25.
    Teragaki M, Nishiguchi S, Takeuchi K, Yoshiyama M, Akioka K, Yoshikawa J (2003) Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomyopathy. Heart Vessels 18: 167–170PubMedCrossRefGoogle Scholar
  26. 26.
    Tanei R, Watanabe K, Nishiyama S (1995) Clinical and histopathologic analysis of the relationship between lichen planus and chronic hepatitis C. J Dermatol 22: 316–323PubMedGoogle Scholar
  27. 27.
    Clark JM (2006) The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 40: S5–10PubMedGoogle Scholar
  28. 28.
    Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387–1395PubMedCrossRefGoogle Scholar
  29. 29.
    Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43: S99–S112PubMedCrossRefGoogle Scholar
  30. 30.
    Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF, Schnohr P, Jensen G (1996) Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 23: 1025–1029PubMedCrossRefGoogle Scholar
  31. 31.
    Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria Croce L, Sasso F, Pozzato G, Cristianini G et al (1997) Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 41: 845–850PubMedGoogle Scholar
  32. 32.
    Rawson JS, Achord JL (1985) Shock liver. South Med J 78: 1421–1425PubMedCrossRefGoogle Scholar
  33. 33.
    Myers RP, Cerini R, Sayegh R, Moreau R, Degott C, Lebrec D, Lee SS (2003) Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology 37: 393–400PubMedCrossRefGoogle Scholar
  34. 34.
    Okuda K, Kage M, Shrestha SM (1998) Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology 28: 1191–1198PubMedCrossRefGoogle Scholar
  35. 35.
    Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC (2003) Budd-Chiari syndrome: a review by an expert panel. J Hepatol 38: 364–371PubMedCrossRefGoogle Scholar
  36. 36.
    Tavill AS (2001) Diagnosis and management of hemochromatosis. Hepatology 33: 1321–1328PubMedCrossRefGoogle Scholar
  37. 37.
    Roberts EA, Schilsky ML (2003) A practice guideline on Wilson disease. Hepatology 37: 1475–1492PubMedCrossRefGoogle Scholar
  38. 38.
    Stoller JK, Aboussouan LS (2005) Alpha1-antitrypsin deficiency. Lancet 365: 2225–2236PubMedCrossRefGoogle Scholar
  39. 39.
    Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H (1998) Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 33: 99–103PubMedCrossRefGoogle Scholar
  40. 40.
    Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929–938PubMedCrossRefGoogle Scholar
  41. 41.
    Obermayer-Straub P, Strassburg CP, Manns MP (2000) Autoimmune hepatitis. J Hepatol 32: 181–197PubMedCrossRefGoogle Scholar
  42. 42.
    LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, Hoofnagle JH (2006) Primary sclerosing cholangitis: summary of a workshop. Hepatology 44: 746–764PubMedCrossRefGoogle Scholar
  43. 43.
    Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353: 1261–1273PubMedCrossRefGoogle Scholar
  44. 44.
    Rahimian J, Wilson T, Oram V, Holzman RS (2004) Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis 39: 1654–1659PubMedCrossRefGoogle Scholar
  45. 45.
    Seeto RK, Rockey DC (1999) Amebic liver abscess: epidemiology, clinical features, and outcome. West J Med 170: 104–109PubMedGoogle Scholar
  46. 46.
    Strickland GT (2006) Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 43: 915–922PubMedCrossRefGoogle Scholar
  47. 47.
    Anand AC, Puri P (2005) Jaundice in malaria. J Gastroenterol Hepatol 20: 1322–1332PubMedCrossRefGoogle Scholar
  48. 48.
    Rozen P, Korn RJ, Zimmerman HJ (1970) Computer analysis of liver function tests and their interrelationships in 347 cases of viral hepatitis. Isr J Med Sci 6: 67–79PubMedGoogle Scholar
  49. 49.
    Kaur S, Rybicki L, Bacon BR, Gollan JL, Rustgi VK, Carey WD (1996) Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results of the National Hepatitis Screening Survey. National Hepatitis Surveillance Group. Hepatology 24: 979–986PubMedGoogle Scholar
  50. 50.
    Whitehead MW, Hawkes ND, Hainsworth I, Kingham JG (1999) A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. Gut 45: 129–133PubMedGoogle Scholar
  51. 51.
    Cohen JA, Kaplan MM (1979) The SGOT/SGPT ratio-an indicator of alcoholic liver disease. Dig Dis Sci 24: 835–838PubMedCrossRefGoogle Scholar
  52. 52.
    Johnson RD, O’Connor ML, Kerr RM (1995) Extreme serum elevations of aspartate aminotransferase. Am J Gastroenterol 90: 1244–1245PubMedGoogle Scholar
  53. 53.
    Henrion J, Minette P, Colin L, Schapira M, Delannoy A, Heller FR (1999) Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 consecutive cases. Hepatology 29: 427–433PubMedCrossRefGoogle Scholar
  54. 54.
    Cassidy WM, Reynolds TB (1994) Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. J Clin Gastroenterol 19: 118–121PubMedCrossRefGoogle Scholar
  55. 55.
    Fortson WC, Tedesco FJ, Starnes EC, Shaw CT (1985) Marked elevation of serum transaminase activity associated with extrahepatic biliary tract disease. J Clin Gastroenterol 7: 502–505PubMedCrossRefGoogle Scholar
  56. 56.
    Williams AL, Hoofnagle JH (1988) Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology 95: 734–739PubMedGoogle Scholar
  57. 57.
    Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM et al (2005) Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 42: 282–292PubMedCrossRefGoogle Scholar
  58. 58.
    Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP et al (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45: 846–854PubMedCrossRefGoogle Scholar
  59. 59.
    Borsch G, Wegener M, Wedmann B, Kissler M, Glocke M (1988) Clinical evaluation, ultrasound, cholescintigraphy, and endoscopic retrograde cholangiography in cholestasis. A prospective comparative clinical study. J Clin Gastroenterol 10: 185–190PubMedCrossRefGoogle Scholar
  60. 60.
    Stewart JS, Farrow LJ, Clifford RE, Lamb SG, Coghill NF, Lindon RL, Sanderson IM, Dodd PA, Smith HG, Preece JW et al (1978) A three-year survey of viral hepatitis in West London. Q J Med 47: 365–384PubMedGoogle Scholar
  61. 61.
    Lednar WM, Lemon SM, Kirkpatrick JW, Redfield RR, Fields ML, Kelley PW (1985) Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 122: 226–233PubMedGoogle Scholar
  62. 62.
    McMahon BJ, Alward WL, Hall DB, Heyward WL, Bender TR, Francis DP, Maynard JE (1985) Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 151: 599–603PubMedGoogle Scholar
  63. 63.
    Gitlin N (1997) Hepatitis B: diagnosis, prevention, and treatment. Clin Chem 43: 1500–1506PubMedGoogle Scholar
  64. 64.
    Hoofnagle JH (1997) Hepatitis C: the clinical spectrum of disease. Hepatology 26: 15S–20SPubMedCrossRefGoogle Scholar
  65. 65.
    Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB (2000) Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 46: 2050–2068PubMedGoogle Scholar
  66. 66.
    Blei AT (2005) Selection for acute liver failure: have we got it right? Liver Transpl 11: S30–34PubMedCrossRefGoogle Scholar
  67. 67.
    Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646–649PubMedCrossRefGoogle Scholar
  68. 68.
    Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM et al (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124: 91–96PubMedCrossRefGoogle Scholar
  69. 69.
    Stapleton JT (1995) Host immune response to hepatitis A virus. J Infect Dis 171Suppl 1: S9–14PubMedGoogle Scholar
  70. 70.
    Cornberg M, Protzer U, Dollinger MM, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P et al (2007) [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011.]. Z Gastroenterol 45: 525–574PubMedCrossRefGoogle Scholar
  71. 71.
    Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE et al (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362–364PubMedCrossRefGoogle Scholar
  72. 72.
    Gretch DR (1997) Use and interpretation of HCV diagnostic tests in the clinical setting. Clin Liver Dis 1: 543–557, viPubMedCrossRefGoogle Scholar
  73. 73.
    Richter SS (2002) Laboratory assays for diagnosis and management of hepatitis C virus infection. J Clin Microbiol 40: 4407–4412PubMedCrossRefGoogle Scholar
  74. 74.
    Pawlotsky JM (1999) Diagnostic tests for hepatitis C. J Hepatol 31(Suppl 1): 71–79PubMedCrossRefGoogle Scholar
  75. 75.
    Yeaman SJ, Fussey SP, Danner DJ, James OF, Mutimer DJ, Bassendine MF (1988) Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1: 1067–1070PubMedCrossRefGoogle Scholar
  76. 76.
    Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R (1998) Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 28: 296–301PubMedCrossRefGoogle Scholar
  77. 77.
    Mulder AH, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CG (1993) Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 17: 411–417PubMedCrossRefGoogle Scholar
  78. 78.
    Colli A, Fraquelli M, Andreoletti M, Marino B, Zuccoli E, Conte D (2003) Severe liver fibrosis or cirrhosis: accuracy of US for detection-analysis of 300 cases. Radiology 227: 89–94PubMedCrossRefGoogle Scholar
  79. 79.
    Saverymuttu SH, Joseph AE, Maxwell JD (1986) Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 292: 13–15Google Scholar
  80. 80.
    Nagata N, Miyachi H, Nakano A, Nanri K, Kobayashi H, Matsuzaki S (2003) Sonographic evaluation of the anterior liver surface in chronic liver diseases using a 7.5-MHz annular-array transducer: correlation with laparoscopic and histopathologic findings. J Clin Ultrasound 31: 393–400PubMedCrossRefGoogle Scholar
  81. 81.
    Aube C, Oberti F, Korali N, Namour MA, Loisel D, Tanguy JY, Valsesia E, Pilette C, Rousselet MC, Bedossa P et al (1999) Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 30: 472–478PubMedCrossRefGoogle Scholar
  82. 82.
    Baik SK, Kim JW, Kim HS, Kwon SO, Kim YJ, Park JW, Kim SH, Chang SJ, Lee DK, Han KH et al (2006) Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology 240: 574–580PubMedCrossRefGoogle Scholar
  83. 83.
    Gaiani S, Gramantieri L, Venturoli N, Piscaglia F, Siringo S, D’Errico A, Zironi G, Grigioni W, Bolondi L (1997) What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 27: 979–985PubMedCrossRefGoogle Scholar
  84. 84.
    Dietrich CF, Lee JH, Herrmann G, Teuber G, Roth WK, Caspary WF, Zeuzem S (1997) Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. Hepatology 26: 467–472PubMedCrossRefGoogle Scholar
  85. 85.
    Perez NE, Siddiqui FA, Mutchnick MG, Dhar R, Tobi M, Ullah N, Saksouk FA, Wheeler DE, Ehrinpreis MN (2007) Ultrasound diagnosis of Fatty liver in patients with chronic liver disease: a retrospective observational study. J Clin Gastroenterol 41: 624–629PubMedCrossRefGoogle Scholar
  86. 86.
    Saini S (1997) Imaging of the hepatobiliary tract. N Engl J Med 336: 1889–1894PubMedCrossRefGoogle Scholar
  87. 87.
    Palma LD (1998) Diagnostic imaging and interventional therapy of hepatocellular carcinoma. Br J Radiol 71: 808–818PubMedGoogle Scholar
  88. 88.
    Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35: 421–430PubMedCrossRefGoogle Scholar
  89. 89.
    Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24: 289–293PubMedCrossRefGoogle Scholar
  90. 90.
    Schluger LK, Sheiner PA, Thung SN, Lau JY, Min A, Wolf DC, Fiel I, Zhang D, Gerber MA, Miller CM et al (1996) Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 23: 971–976PubMedCrossRefGoogle Scholar
  91. 91.
    Mirandola S, Realdon S, Iqbal J, Gerotto M, Dal Pero F, Bortoletto G, Marcolongo M, Vario A, Datz C, Hussain MM et al (2006) Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology 130: 1661–1669PubMedCrossRefGoogle Scholar
  92. 92.
    Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HC Jr, Balart LA, Ortego TJ, Payne J, Dienstag JL et al (1993) Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 104: 595–603PubMedGoogle Scholar
  93. 93.
    Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1: 431–435PubMedCrossRefGoogle Scholar
  94. 94.
    Bach N, Thung SN, Schaffner F (1992) The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 15: 572–577PubMedCrossRefGoogle Scholar
  95. 95.
    Burak KW, Angulo P, Lindor KD (2003) Is there a role for liver biopsy in primary sclerosing cholangitis? Am J Gastroenterol 98: 1155–1158PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2008

Authors and Affiliations

  • Martin F. Sprinzl
    • 1
  • Peter R. Galle
    • 1
  1. 1.1. Medizinische KlinikJohannes Gutenberg-UniversitätMainzGermany

Personalised recommendations